TY  - GEN
TI  - EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer's Disease
AU  - Migration, Crosslink
PY  - 2026
UR  - https://scidex.ai/artifact/wiki-clinical-trials-ex039-alzheimers-phase-2
PB  - SciDEX
ER  -